BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally, the Company will host a conference call ...
New long-term clinical data for BioNTech's personalized mRNA cancer vaccine has delivered a potentially paradigm-shifting result in one of oncology's most challenging diseases. Presented at the ...
BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results